Super Purchasing for Pumpkin Seed Extract in Guyana
Super Purchasing for Pumpkin Seed Extract in Guyana Detail:
[Latin Name] Cucurbita pepo
[Plant Source]from China
[Specifications] 10:1 20:1
[Appearance] Brown yellow fine powder
Plant Part Used:Seed
[Particle size] 80 Mesh
[Loss on drying] ≤5.0%
[Heavy Metal] ≤10PPM
[Storage] Store in cool & dry area, keep away from the direct light and heat.
[Shelf life] 24 Months
[Package] Packed in paper-drums and two plastic-bags inside.
[Net weight] 25kgs/drum
Introduction
Pumpkin seed is used medicinally to help improve bowel function by ridding the intestinal tract of parasites and worms.
As raw material of drugs for eliminating insecticide, swelling, andpertussis, pumpkin seed extract is widely used in pharmaceutical industry;
As product of treating malnutrition and prostate, pumpkin seed extract is widely used in health industry.
FUNCTION:
1.Pumpkin seed extract can help to prevent the prostate disease.
2.Pumpkin seed extract has the function of treating whooping cough and children with sorethroat.
3.Pumpkin is also a natural source of magnesium, phosphorus, selenium, zinc, vitamin A, and vitamin C.
4.The cushaw extract is also a laxative, which can help to moisture the skin, is indeed a good beauty food for women.
5.Pumpkin seed is used medicinally to help improve bowel function by ridding the intestinal tract of parasites and worms.
6.The cushaw seed extract have much acid , this acid can relax the rest angina, and have a function to low the high blood liquid
Product detail pictures:
Related Product Guide:
Quality comes first; service is foremost; business is cooperation" is our business philosophy which is constantly observed and pursued by our company for Super Purchasing for Pumpkin Seed Extract in Guyana , The product will supply to all over the world, such as: Portland, Austria, Lyon, To make every client satisfied with us and achieve win-win success, we will continue to try our best to serve and satisfy you! Sincerely looking forward to cooperating with more overseas customers based on mutual benefits and great future business. Thank you.
Title: Pneumococcal infections and vaccination.
4th International Conference on Vaccines & Vaccination
September 24-26, 2014 Valencia, Spain
OMICS International: https://omicsonline.org
Vaccine Conferences: https://conferenceseries.com/immunolog…
Global Medical Conferences: https://conferenceseries.com
Global Pharmaceutical Conferences: https://pharmaceuticalconferences.com
Global Cancer Conferences: https://cancersummit.org
Global Diabetes Conferences: https://diabetesexpo.com
Global Dental Conferences: https://dentalcongress.com
Global Nursing Conferences: https://nursingconference.com
Abstract
Pneumococci are major contributors to morbidity and mortality worldwide. They are the major cause of milder respiratory tract infections such as otitis and sinusitis, but also to more severe invasive infections such as community-acquired pneumonia with associated septicemia and meningitis. Even though being a devastating pathogen, pneumococci are also common colonizers of the upper respiratory tract of healthy children where from they may spread to cause disease. Risk groups for acquiring an invasive pneumococcal infection (IPD) include preschool children and the elderly, as well as immunocompromised individuals, splenectomised, and patients with a previous influenza virus infection. Several bacterial virulence factors have been described for pneumococci of which a major one is the capsular polysaccharide. Depending on differences in these capsular structures so far more than 90 different serotypes have been distinguished. Recently so called conjugated vaccines (PCV) have been introduced into the child hood vaccination program in many countries. These vaccines are based on a limited amount (7, 10 or 13) of the capsular serotypes. In Sweden PCVs were introduced in the whole of Sweden year 2009. Vaccine introduction has led to a reduction in the incidence of IPD in vaccinated children but also to serotype replacementand an increase of non-vaccine type disease.
Biography
Birgitta Henriques Normark is professor and head physician in Clinical microbiology at Karolinska Institute and Karolinska University hospital, as well as head physician at the Public Health Agency of Sweden. She is also vice dean for recruitment at Karolinska Institutet and a board member of the Swedish Research Council, Medicine and Health.Her research focuses on epidemiology, antibiotic resistance and host-microbe interactions in bacterial infections with special focus on pneumococcal epidemicity, molecular epidemiology, and mechanisms of invasive disease, innate immunity and host-microbe interactions determining disease outcome. The research has been published in 136 publications of which 107 are original peer reviewed articles.
What is the difference between ZXT and Zi Xiu tang ? Find out here.
By Fay from Pretoria - 2018.12.25 12:43
Customer service staff and sales man are very patience and they all good at English, product's arrival is also very timely, a good supplier.
By Penelope from Mozambique - 2018.09.23 18:44